Correlation Between Aerovate Therapeutics and Ideaya Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Ideaya Biosciences, you can compare the effects of market volatilities on Aerovate Therapeutics and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Ideaya Biosciences.

Diversification Opportunities for Aerovate Therapeutics and Ideaya Biosciences

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and Ideaya is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Ideaya Biosciences go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Ideaya Biosciences

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.33 times more return on investment than Ideaya Biosciences. However, Aerovate Therapeutics is 1.33 times more volatile than Ideaya Biosciences. It trades about 0.22 of its potential returns per unit of risk. Ideaya Biosciences is currently generating about -0.11 per unit of risk. If you would invest  219.00  in Aerovate Therapeutics on August 31, 2024 and sell it today you would earn a total of  45.00  from holding Aerovate Therapeutics or generate 20.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Ideaya Biosciences

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ideaya Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Aerovate Therapeutics and Ideaya Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Ideaya Biosciences

The main advantage of trading using opposite Aerovate Therapeutics and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.
The idea behind Aerovate Therapeutics and Ideaya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device